Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Subcutaneous Drug Delivery Devices Market Forecast: Value Set To Climb From $32.03 Billion To $42.41 Billion
The subcutaneous drug delivery devices market has experienced substantial growth in recent years. This market is projected to expand from $29.77 billion in 2025 to $32.03 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.6%. Historically, factors contributing to this expansion include the increasing incidence of diabetes and various chronic conditions, the greater adoption of insulin pens and pen needles, the development of hospital and clinic infrastructure, the restricted access to advanced delivery technologies, and enhanced understanding of subcutaneous drug administration.
The subcutaneous drug delivery devices market is anticipated to experience substantial expansion over the next few years. It is projected to reach a valuation of $42.42 billion by 2030, showing a compound annual growth rate (CAGR) of 7.3%. This growth during the forecast period is attributed to several factors, including the expansion of biologics and oncology therapies, the increasing use of smart auto-injectors, the broader establishment of homecare settings, advancements in implantable pump technology, and a rising need for patient-focused drug delivery solutions. Prominent trends expected in this period encompass a surge in the adoption of auto-injectors and smart injection devices, a growing preference for home-based and self-administration treatments, an increasing demand for minimally invasive drug delivery methods, the broadening of applications for biologic and biosimilar drug delivery, and improved patient adherence achieved through user-friendly device designs.
Get A Free Sample Report With In-Depth Market Insights:
Subcutaneous Drug Delivery Devices Market Growth Momentum: What Factors Are Shaping Demand?
The escalating incidence of diabetes and cardiovascular diseases (CVD) is anticipated to propel the growth of the subcutaneous drug delivery devices market moving forward. This rising prevalence of diabetes and cardiovascular conditions is fueled by aging populations, unhealthy diets, sedentary lifestyles, obesity, socioeconomic inequalities, stress, environmental factors, and limited access to preventive healthcare. Subcutaneous drug delivery devices serve to administer insulin and other medications for glycemic control in diabetes, and to supply drugs like anticoagulants or lipid-lowering agents in cardiovascular diseases, offering a convenient and regulated approach to manage these chronic ailments. For instance, in October 2024, the Centers for Disease Control and Prevention, a US-based federal agency, reported that 919,032 people died from cardiovascular disease in 2023, which is equivalent to 1 in every 3 deaths. Consequently, the increasing prevalence of diabetes and cardiovascular diseases (CVD) is driving growth in the subcutaneous drug delivery devices market.
Subcutaneous Drug Delivery Devices Market Segment Analysis And Revenue Potential
The subcutaneous drug delivery devices market covered in this report is segmented –
1) By Product Type: Insulin Pens, Pen Needles, Injector Pens, Auto-Injectors, Implantable Pumps
2) By Application: Diabetes, Fertility, Oncology
3) By End-User: Hospitals And Clinics, Homecare Settings, Ambulatory Surgical Centers
Subsegments:
1) By Insulin Pens: Disposable Insulin Pens, Reusable Insulin Pens
2) By Pen Needles: Standard Pen Needles, Safety Pen Needles
3) By Injector Pens: Disposable Injector Pens, Reusable Injector Pens
4) By Auto-Injectors: Manual Auto-Injectors, Smart Auto-Injectors
5) By Implantable Pumps: Insulin Pumps, Drug Infusion Pumps
Subcutaneous Drug Delivery Devices Market Trends Redefining Industry Growth
Key players operating within the subcutaneous drug delivery devices market are dedicating efforts to developing innovative products, such as miniature digital liquid flow sensors. This focus aims to bolster the safety and precision of subcutaneous drug administration by offering accurate, customizable flow sensors for large-volume injectors. Miniature digital liquid flow sensors are compact instruments that accurately gauge the flow rate of liquids in small-scale applications, providing digital output for precise monitoring and control. As an example, in May 2024, Sensirion AG, a Switzerland-based provider of environmental and flow sensors, launched its SLD3x series sensor platform. This sensor series incorporates highly accurate digital liquid flow sensors with customizable options, delivering exact flow measurement, occlusion detection, in-line air bubble identification, and liquid temperature monitoring. These miniature sensors are perfectly suited for large-scale medical device manufacturing, guaranteeing optimal dosing and elevated patient safety in subcutaneous drug delivery.
Subcutaneous Drug Delivery Devices Market Key Players Shaping Industry Direction
Major companies operating in the subcutaneous drug delivery devices market are Pfizer Inc., Sanofi S.A., Roche Holdings Inc., Medtronic plc, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Becton Dickinson and Company, West Pharmaceutical Services Inc., Gerresheimer AG, Insulet Corporation, SHL Medical AG, Tandem Diabetes Care Inc., Ypsomed Holding AG, Nemera, Elcam Medical Ltd., Owen Mumford Ltd., Haselmeier GmbH, Sensile Medical AG, Enable Injections Inc., Unilife Corporation, PharmaJet, Oval Medical Technologies Ltd.
View The Full Subcutaneous Drug Delivery Devices Market Report:
Subcutaneous Drug Delivery Devices Market Geographic Analysis: Where Is Demand Rising Fastest?
North America was the largest region in the subcutaneous drug delivery devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the market going forward. The regions covered in the subcutaneous drug delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
